How I Diagnose Patients with AML Based on Minimal Residual Disease Testing

Description

Upon viewing this session, you will be able to:
• Describe the advantages and limitations of techniques used for AML MRD assessment
• Recognize the importance of AML MRD for prognostication
• End of Induction
• Pre- and Post-transplant
• Explain the appropriate interpretation of MRD assays dependence on therapy, time point and biologic risk group
• Appreciate the advantages and limitations of high-sensitivity AML MRD assays

Presenters

  • Brent Wood, MD, PhD, University of Washington

Pricing

Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top